Search Results - "Sopher G"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Cost-effectiveness analysis of ribociclib versus abemaciclib as first-line treatments for postmenopausal women with HR+/HER2- advanced breast cancer: a Medicare perspective.

    Authors: Tarantino P Sammons S Gadi VK et al.

    Source: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 2125-2134. Date of Electronic Publication: 2025 Dec 05.

    Publication Type: Journal Article

    Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Comparative cost-effectiveness of ribociclib and palbociclib as first-line treatment for HR+/HER2- advanced breast cancer in postmenopausal women: analysis from a Medicare perspective.

    Authors: Sammons S Tarantino P Gadi VK et al.

    Source: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 2150-2160. Date of Electronic Publication: 2025 Dec 08.

    Publication Type: Journal Article; Comparative Study

    Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Economic value of ribociclib in early breast cancer in the United States.

    Authors: Brufsky A Tolaney SM Gadi VK et al.

    Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2026 Aug; Vol. 32 (8), pp. 911-922.

    Publication Type: Journal Article

    Journal Info: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE

    Save to List
  4. 4

    Real-world postprogression outcomes after first-line treatment with ribociclib plus aromatase inhibitor versus aromatase inhibitor alone in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States of America.

    Authors: Hart L Rugo HS Sharma P et al.

    Source: ESMO open [ESMO Open] 2026 Jul; Vol. 11 (7), pp. 108243. Date of Electronic Publication: 2026 Jul 07.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

    Save to List
  5. 5

    Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer.

    Authors: Sammons S Yardley DA Sharma P et al.

    Source: Oncology and therapy [Oncol Ther] 2026 Mar; Vol. 14 (1), pp. 19-25. Date of Electronic Publication: 2025 Nov 14.

    Publication Type: Editorial

    Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther Subsets: PubMed not MEDLINE

    Save to List
  6. 6

    Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2- advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, -3, and -7 trials.

    Authors: Hart LL Im SA Tolaney SM et al.

    Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Feb 25; Vol. 217, pp. 115225. Date of Electronic Publication: 2025 Jan 08.

    Publication Type: Journal Article; Randomized Controlled Trial

    Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

    Save to List
  7. 7

    Hepatitis C virus infection in acquired aplastic anemia.

    Authors: Paquette RL Kuramoto K Tran L et al.

    Source: American journal of hematology [Am J Hematol] 1998 Jun; Vol. 58 (2), pp. 122-6.

    Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

    Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Print ISSN: 0361-8609 (Print) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

    Save to List

Search Tools: